||Griffith R. Morris
Mr. Morris serves as Managing Partner of Morris Loflin & Company, Inc., (MLC), headquartered in Basking Ridge, NJ. He is a recognized energy industry expert with extensive experience serving utilities, regulatory authorities and industrial companies nationally and abroad. His focus is upon advising senior client executives on project construction, operations, financial condition and planning, and regulatory compliance.
Prior to co-founding MLC, he served as Senior Vice President and a member of the Board of Directors of Stone & Webster Management Consultants, Inc., where he led the firm’s Marketing, Corporate Development, Financial Services, Risk Management, and Operations Consulting Groups.
Preceding this, Mr. Morris was Vice President and Managing Director-Utility Finance with Kidder, Peabody & Company, Inc., in which capacity he identified and closed on $2.5 Billion in financings as managing underwriter for electric and gas utilities. Earlier, Mr. Morris was with Booz Allen Hamilton as Principal-Utility Practice, a then-new initiative of the firm. Under his leadership, the Practice attained annual fees of $10 Million in its second year.
Mr. Morris is an established Expert Witness, and has testified under oath on behalf of 22 utility clients in 12 states before state regulators, the FERC, state and federal courts, the New York State Energy Committee and the US Senate Finance Committee on such matters as capacity needs and utilization, financing and construction plans, customer costs, regional economic impact and regulatory compliance.
Mr. Morris holds undergraduate degrees in Applied Mathematics (Adelphi College), Electrical Engineering (New York University) and an Executive MBA (Harvard Business School). He is a member of the NYSSA and the IEEE and serves on the Advisory Boards of two private energy industry firms.
Back to top
Jonathan M. Raines, M.D.
Dr. Raines has an extensive background in both the medical/scientific and business fields. He currently is on the staff of both the University of Pennsylvania and Main Line Health Systems, and maintains an active private practice in psychiatry and psychoanalysis, and consultation to the entrepreneurial community. He is also a member of the faculty of The Center for Psychoanalysis at Albert Einstein Medical Center, The Psychoanalytic Center of Philadelphia, and is a Visiting Professor at the Lankenau Institute for Medical Research. He has published in fields ranging from psycho pharmacology through complex aspects of psychological disorganization. He has been active in organized psychiatry at the local and national level and was elected and appointed to a variety of offices.
In addition, Dr. Raines is CEO and President of Fried Products Corporation which manufactures and distributes high end audiophile equipment. He has held this position since 2004.
Dr. Raines holds a B.A. from The University of Pennsylvania and an M.D. from Temple University. He pursued his Internship at Pennsylvania Hospital and Residency at The Institute of the Pennsylvania Hospital. Dr. Raines received his training in psychoanalysis at The Philadelphia Association for Psychoanalysis, is Certified by The Board of Professional Standards of the American Psychoanalytic Association, and is the recipient of numerous awards and honors.
Back to top
Stanley Rose, Ph.D.
Dr. Rose has a strong scientific and operating background in biotechnology, and has been a founder and manager of related successful companies. He currently is President and Chief Executive of NimbleGen Systems and member of the Board of Directors. NimbleGen is a leading supplier of flexible high-density microarray products and services for the enhancement of genomic analysis, including the ability to obtain and integrate complex genetic data sets not previously accessible. The Company utilizes Maskless Array Synthesis, developed in collaboration with the University of Wisconsin, as its underlying technology to synthesize DNA.
Previously, Dr. Rose was the founder of Genetic Microsystems, a microarray products company which was sold in 2000. Earlier in his career, he directed the PCR technology business during its most dynamic growth phases for Perkin Elmer and Applied Microsystems.
Dr. Rose received his BA. degree from Cornell University and his Ph.D. from the Massachusetts Institute of Technology.
Back to top